A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ozanimod Bromo Impurity - Request Quote

Picture of Ozanimod Bromo Impurity

Ozanimod Bromo Impurity

SZ CAT No:SZ-O035003
CAS No
NA
Mol.F.
C22H24BrN3O3
Mol.Wt.
458.4
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ozanimod Bromo Impurity is chemically (S)-2-((4-(5-(3-Bromo-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)ethan-1-ol. Ozanimod Bromo Impurity is supplied with detailed characterization data compliant with regulatory guideline. Ozanimod Bromo Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ozanimod.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ozanimod Bromo Impurity

Purchase Ozanimod Bromo Impurity

Ozanimod Bromo Impurity suppliers

Ozanimod Bromo Impurity manufacturers

Ozanimod Bromo Impurity price

Order Ozanimod Bromo Impurity

Enquire Ozanimod Bromo Impurity

Ozanimod Bromo Impurity cost

Ozanimod Bromo Impurity Supplier

Ozanimod Bromo Impurity Distributor

Ozanimod Bromo Impurity for Method Validation

Ozanimod Reference Standard

Ozanimod Bromo Impurity for ANDA Filing

Ozanimod Bromo Impurity for Forced Degradation Studies

Ozanimod Bromo Impurity Identification Standards

Ozanimod Bromo Impurity for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,